We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+26.28%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$171M
AUM Growth
+$47.3M
Cap. Flow
+$20.1M
Cap. Flow %
11.76%
Top 10 Hldgs %
88.23%
Holding
35
New
6
Increased
3
Reduced
2
Closed
15

Top Buys

Rank Stock Value
1
TRML
Tourmaline Bio
TRML
+$6.39M
2
ACRS icon
Aclaris Therapeutics
ACRS
+$5.37M
3
ROIV icon
Roivant Sciences
ROIV
+$4.87M
4
ADMA icon
ADMA Biologics
ADMA
+$1.48M
5
IMVT icon
Immunovant
IMVT
+$1.01M

Top Sells

Rank Stock Value
1
QIPT
Quipt Home Medical
QIPT
+$5.6M
2
TELA icon
TELA Bio
TELA
+$3.86M
3
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.15M
4
GOSS icon
Gossamer Bio
GOSS
+$2.55M
5
CABA icon
Cabaletta Bio
CABA
+$2.28M

Sector Composition

Rank Sector Weight
1 Healthcare 82.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IFRX icon
26
InflaRx
IFRX
$296M
– –
-200,000
Closed -$596K
IOVA icon
27
CALL
Iovance Biotherapeutics
IOVA
$3.05B
– –
-250,000
Closed -$1.14M
MLTX icon
28
MoonLake Immunotherapeutics
MLTX
$1.47B
– –
-55,300
Closed -$3.15M
QIPT
29
CALL
DELISTED
Quipt Home Medical
QIPT
– –
-100,000
Closed -$509K
QIPT
30
DELISTED
Quipt Home Medical
QIPT
– –
-1,100,000
Closed -$5.6M
RZLT icon
31
Rezolute
RZLT
$453M
– –
-400,000
Closed -$528K
THC icon
32
Tenet Healthcare
THC
$21.5B
– –
-24,937
Closed -$1.64M
ASLN
33
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
– –
-78,125
Closed -$1.18M
ICVX
34
DELISTED
Icosavax, Inc. Common Stock
ICVX
– –
-160,630
Closed -$1.24M
INBX
35
DELISTED
Inhibrx, Inc. Common Stock
INBX
– –
-25,000
Closed -$459K
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Velan Capital Investment Management held 35 positions worth $171M, up 38% from $124M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Velan Capital Investment Management deployed $20.1M of net new capital in Q4 2023, opening 6 new positions and adding to 3 existing holdings. Its largest new stake was Tourmaline Bio: 319,080 shares worth $8.35M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was TELA Bio, an estimated $3.86M trimmed.

  • Velan Capital Investment Management's largest Q4 2023 buy was Tourmaline Bio: 319,080 shares worth $8.35M.
  • Velan Capital Investment Management added most to ADMA Biologics in Q4 2023, an estimated $1.48M increase.
  • Velan Capital Investment Management's biggest Q4 2023 reduction was TELA Bio, cutting an estimated $3.86M.
  • Velan Capital Investment Management fully exited Quipt Home Medical in Q4 2023, selling an estimated $5.6M.
  • Velan Capital Investment Management's ten largest holdings make up 88% of its $171M portfolio in Q4 2023.
  • Velan Capital Investment Management opened 6 new positions and closed 15 in Q4 2023.
  • Velan Capital Investment Management's portfolio value rose 38% quarter-over-quarter to $171M.

Based on Velan Capital Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.